LC
HAE icon

Lindbrook Capital’s Haemonetics HAE Stock Holding History

Lindbrook Capital’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$6.93K Buy
109
+70
+179% +$4.76K ﹤0.01% 1812
2024
Q4 		$3.04K Hold
39
– – ﹤0.01% 2171
2024
Q3 		$3.13K Sell
39
-91
-70% -$7.35K ﹤0.01% 2201
2024
Q2 		$10.8K Sell
130
-46
-26% -$4.05K ﹤0.01% 1583
2024
Q1 		$15K Sell
176
-45
-20% -$3.53K ﹤0.01% 1362
2023
Q4 		$18.9K Sell
221
-26
-11% -$2.25K ﹤0.01% 1206
2023
Q3 		$22.1K Buy
247
+68
+38% +$6.07K ﹤0.01% 1012
2023
Q2 		$15.2K Hold
179
– – ﹤0.01% 1231
2023
Q1 		$14.8K Buy
179
+46
+35% +$3.72K ﹤0.01% 1215
2022
Q4 		$10.5K Buy
133
+88
+196% +$7.07K ﹤0.01% 1413
2022
Q3 		$3K Buy
45
+25
+125% +$1.79K ﹤0.01% 1872
2022
Q2 		$1K Buy
20
+5
+33% +$296 ﹤0.01% 2253
2022
Q1 		$1K Buy
+15
New +$816 ﹤0.01% 2246
2021
Q4 		– Sell
-44
Closed -$3K – 2130
2021
Q3 		$3K Buy
+44
New +$2.78K ﹤0.01% 1411
2021
Q2 		– Sell
-11
Closed -$1K – 1947
2021
Q1 		$1K Buy
+11
New +$1.36K ﹤0.01% 1729
2020
Q3 		– Sell
-6
Closed -$1K – 1784
2020
Q2 		$1K Hold
6
– – ﹤0.01% 1564
2020
Q1 		$1K Buy
+6
New +$651 ﹤0.01% 1462

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Lindbrook Capital's HAE Position: Q1 2025 in Review

Lindbrook Capital increased its Haemonetics (HAE) stake by 179% in Q1 2025, buying an estimated $4.76K and bringing the position to 109 shares worth $6.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1812.

Lindbrook Capital first reported a position in HAE in Q1 2020 and has held it in 17 quarters since. The position peaked at $22.1K in Q3 2023. 314 funds tracked by Wall St. Rank hold HAE as of Q1 2025.

  • Lindbrook Capital held 109 shares of Haemonetics worth $6.93K as of Q1 2025.
  • Lindbrook Capital bought 70 Haemonetics shares in Q1 2025, an estimated $4.76K.
  • Haemonetics made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1812 holding.
  • Lindbrook Capital first reported a position in Haemonetics in Q1 2020 and has held it in 17 quarters since.
  • Lindbrook Capital's Haemonetics position peaked at $22.1K in Q3 2023.
  • 314 funds tracked by Wall St. Rank held Haemonetics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.